"My challenge is to drive sales growth of our products in a market gripped by two anti-growth forces: increasing competition and decreasing access to sales opportunities"- Trace Cawley, Sales & Marketing of Spinal Products at the Kyocera Medical Technologies, Inc. in Texas, U.S.A.
The U.S. orthopedic implants market makes up roughly 60% of the global market, comprising a large number of players with products becoming more commoditized.
KMTI is a U.S.-based company that develops and sells orthopedic implants such as spinal and joint implants. Kyocera has a rich history of developing advanced technologies that stand apart from competitors and open new market segments. KMTI is evaluating several advanced technologies that not only complement our existing products, but also open entirely new business segments which will allow us to grow rapidly, unchallenged, and with much greater profitability.
Learn more about KMTI here:
https://kyocera-medical.com/
Learn more about Kyocera's operations in the medical and healthcare markets by watching the video below:
https://global.kyocera.com/company/movie/index.html
Related News
-
Kyocera to Construct New Development Center at Shiga Yasu Campus in Japan
-
News
Kyocera to Construct New Development Center at Shiga Yasu Campus in Japan
-
Welcome to MIMOSA
-
My Favorite Engineer Interview #28:Noriko from Kyocera Japan
-
My Favorite Engineer Interview #27: Funatsu from Kyocera Japan
-
My Favorite Engineer Interview #26: Enrin from Kyocera MMRC
-
Aquala technology for Artificial Joints
-
Aquala technology for Artificial Joints
-
Osteon Digital
-
News
Kyocera Receives Gold Rating on EcoVadis Sustainability Survey, Second Consecutive Year
-
Project Our Abilities Into the Future
-
My Favorite Engineer Interview #25: Ayaka from Kyocera Japan
Related SitesDirect site link
Related Videos